Clinical Trials Logo

Inflammation Corneal clinical trials

View clinical trials related to Inflammation Corneal.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04130802 Completed - Pain, Postoperative Clinical Trials

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

SKYGGN
Start date: September 27, 2019
Phase: Phase 2
Study type: Interventional

The DX-216 trial is a randomized, double-masked, placebo (vehicle)-controlled study evaluating the efficacy and safety of two doses of OCS-01 compared to vehicle in the treatment of inflammation and pain following cataract surgery. The primary objective is to evaluate the efficacy and safety of OCS-01 compared to placebo and the secondary objective is to evaluate the optimal dosing frequency (once a day [QD] or twice a day [BID]).